NEW YORK ( TheStreet) -- Natural Alternatives International (Nasdaq: NAII) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel these strengths outweigh the fact that the company shows low profit margins.

Highlights from the ratings report include:
  • NATURAL ALTERNATIVES reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. During the past fiscal year, NATURAL ALTERNATIVES increased its bottom line by earning $0.71 versus $0.57 in the prior year.
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Personal Products industry. The net income increased by 1339.9% when compared to the same quarter one year prior, rising from $0.22 million to $3.14 million.
  • Despite its growing revenue, the company underperformed as compared with the industry average of 5.8%. Since the same quarter one year prior, revenues slightly increased by 0.2%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • NAII has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 3.77, which clearly demonstrates the ability to cover short-term cash needs.

Natural Alternatives International, Inc. provides private label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers in the United States and internationally. The company has a P/E ratio of 8.7, above the average drugs industry P/E ratio of 8.6 and below the S&P 500 P/E ratio of 17.7. Natural Alternatives International has a market cap of $42.8 million and is part of the health care sector and drugs industry. Shares are up 9.3% year to date as of the close of trading on Tuesday.

You can view the full Natural Alternatives International Ratings Report or get investment ideas from our investment research center.
null